NFSG
APTO

Newbridge Financial Services Group’s Aptose Biosciences, Inc. APTO Stock Holding History

Newbridge Financial Services Group’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26
Closed -$82 – 1379
2025
Q1 		$82 Sell
26
-2
-7% -$10 ﹤0.01% 1016
2024
Q4 		$187 Hold
28
– – ﹤0.01% 1090
2024
Q3 		$342 Hold
28
– – ﹤0.01% 620
2024
Q2 		$631 Hold
28
– – ﹤0.01% 1013
2024
Q1 		$1.38K Hold
28
– – ﹤0.01% 1026
2023
Q4 		$2.11K Hold
28
– – ﹤0.01% 962
2023
Q3 		$2.33K Sell
28
-4
-13% -$471 ﹤0.01% 1055
2023
Q2 		$4.48K Hold
32
– – ﹤0.01% 1027
2023
Q1 		$9.28K Hold
32
– – ﹤0.01% 923
2022
Q4 		$8.41K Hold
32
– – ﹤0.01% 948
2022
Q3 		$9K Hold
32
– – 0.01% 920
2022
Q2 		$11K Hold
32
– – 0.01% 850
2022
Q1 		$20K Hold
32
– – 0.01% 738
2021
Q4 		$20K Hold
32
– – 0.01% 737
2021
Q3 		$32K Hold
32
– – 0.02% 542
2021
Q2 		$48K Hold
32
– – 0.03% 455
2021
Q1 		$87K Hold
32
– – 0.06% 281
2020
Q4 		$64K Buy
32
+11
+52% +$25.8K 0.05% 283
2020
Q3 		$57K Buy
+21
New +$52.4K 0.06% 298

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return

Newbridge Financial Services Group's APTO Position: Q2 2025 in Review

Newbridge Financial Services Group sold out of Aptose Biosciences, Inc. (APTO) in Q2 2025, closing a stake of 26 shares — an estimated $82 sold.

Newbridge Financial Services Group first reported a position in APTO in Q3 2020 and held it in 19 quarters. The position peaked at $87K in Q1 2021. 4 funds tracked by Wall St. Rank hold APTO as of Q2 2025.

  • Newbridge Financial Services Group reported no remaining Aptose Biosciences, Inc. position as of Q2 2025 after selling out during the quarter.
  • Newbridge Financial Services Group sold 26 Aptose Biosciences, Inc. shares in Q2 2025, an estimated $82.
  • Newbridge Financial Services Group first reported a position in Aptose Biosciences, Inc. in Q3 2020 and held it in 19 quarters.
  • Newbridge Financial Services Group's Aptose Biosciences, Inc. position peaked at $87K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2025.

Based on Newbridge Financial Services Group's 13F filing for Q2 2025, filed 19 Aug 2025.